Annual report
3604.TEDINET S100R056
Period2022-04-01 → 2023-03-31
Filed2023-06-21
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥30.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥30.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥692m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥741m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥825m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥857m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥299m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥81m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥945m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥747m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥643m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥255m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥71m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥766m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥651m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥19.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥17.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥17.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.6bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.2bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥4.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.7bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥774m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥175m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥467m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥978m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥624m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥953m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥705m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥327m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥142m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥250m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥858m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥444m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥681m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥676m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥128.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥236.49 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.91 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.17 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,146.87 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,019.15 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥916.85 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥676.18 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥632.69 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 34.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.0% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 29.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 1.9% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 444 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 395 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 389 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 376 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 343 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥28.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥28.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥28.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥23.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥655m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥610m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥726m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥954m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥966m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥194m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥725m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥502m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥781m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥247m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥171m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥17.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥16.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥16.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥13.1bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥11.5bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥10.6bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥6.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.1bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.9bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥572m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥620m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥86.63 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.79 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.87 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.63 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.5 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥16 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,048.6 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥977.11 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥882.88 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥684.82 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥664.53 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 34.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,000,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 232 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 239 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 234 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 244 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 250 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥22m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2023-03-31 | −¥559m |
| Consumerreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥21m |
| Consumerreportable segment | employees | at 2023-03-31 | 72 pure |
| Consumerreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥21.9bn |
| Consumerreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥21.9bn |
| Consumerreportable segment | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| Medicalreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥181m |
| Medicalreportable segment | employees | at 2023-03-31 | 295 pure |
| Medicalreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥8.5bn |
| Medicalreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥8.5bn |
| Medicalreportable segment | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥359m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥202m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥30.4bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥30.4bn |
| —segment total | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥1.4bn |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥40m |
| Reconciling Itemsreconciling | segment ordinary income | 2021-04-01 → 2022-03-31 | −¥496m |
| Consumerreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥17m |
| Consumerreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥21.5bn |
| Consumerreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥21.5bn |
| Consumerreportable segment | segment ordinary income | 2021-04-01 → 2022-03-31 | ¥967m |
| Medicalreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥143m |
| Medicalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥8.6bn |
| Medicalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥8.6bn |
| Medicalreportable segment | segment ordinary income | 2021-04-01 → 2022-03-31 | ¥386m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥160m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥30.1bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥30.1bn |
| —segment total | segment ordinary income | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Consumerreportable segment | employees | at 2023-03-31 | 35 pure |
| Medicalreportable segment | employees | at 2023-03-31 | 175 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,581
| Item | Context | Value | Unit |
|---|---|---|---|
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)ピジョン㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)当社の仕入先であり、安定した仕入取引の継続を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)旭化成㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)オカモト㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)㈱メディパルホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)㈱しまむら | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)大木ヘルスケアホールディングス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)同社傘下の企業は当社の販売先であり、良好な取引関係の維持、強化を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)小津産業㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)当社の仕入先であり、安定した仕入取引の継続を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row8Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)ウエルシアホールディングス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)同社傘下の企業は当社の販売先であり、良好な取引関係の維持、強化を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row9Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)㈱西松屋チェーン | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)当社の主要な販売先であり、同社との良好な取引関係の維持、強化を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row10Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)㈱大塚商会 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row11Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)㈱バイタルケーエスケー・ホールディングス | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)同社傘下の企業は当社の販売先であり、良好な取引関係の維持、強化を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row12Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)不二ラテックス㈱ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)当社の仕入先であり、安定した仕入取引の継続を目的として保有しております。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row13Member | Original text (Japanese)無 | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |